Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

MXC.L (MXC) Share Price

There is currently no data for MXC.L

MXC.L (MXC) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
See more MXC.L trades

MXC.L (MXC) Share Price History

Time period:
to
Date Open High Low Close Volume
See more MXC.L price history

MXC.L (MXC) Regulatory News

Date Source Headline
3rd Apr 2024 7:30 am RNS Suspension - MGC Pharmaceuticals Limited
2nd Apr 2024 3:40 pm RNS Change of name to Argent BioPharma Limited
28th Mar 2024 9:12 am RNS PDMR Notification
28th Mar 2024 9:07 am RNS Refinancing of Convertible Securities Agreement
18th Mar 2024 8:23 am RNS Results of General Meeting
29th Feb 2024 9:36 am RNS Half-year Report
19th Feb 2024 4:00 pm RNS Update - Application for Admission to Trading
13th Feb 2024 10:00 am RNS Dispatch of General Meeting Documents
31st Jan 2024 7:30 am RNS December 2023 Quarter Activity Report
11th Jan 2024 9:54 am RNS Director/PDMR Shareholding
See more MXC.L regulatory news

MXC.L (MXC) Share News

UK shareholder meetings calendar - next 7 days

11th Mar 2024 15:42

Read More

EARNINGS: Leeds awaiting Hemmers sale, Macfarlane ups full-year payout

29th Feb 2024 17:00

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

IN BRIEF: MGC Pharmaceuticals proposes name change to Argent Biopharma

13th Feb 2024 11:54

MGC Pharmaceuticals Ltd - pharmaceutical company specialising in plant-derived medicines - Calls general meeting for March 18 on resolution to change the company's name to Argent Biopharma Ltd. "The board proposes this change of name on the basis that it believes the proposed name more accurately reflects the future operations of the company," the firm says. Read More

MGC Pharma gets Saudi approval for Covid-19 over-the-counter treatment

19th Dec 2023 18:04

(Alliance News) - MGC Pharmaceuticals Ltd on Tuesday said the Saudi Arabian Food & Drug Authority has granted approval for its proprietary Covid-19 treatment product ArtemiC as an over-the-counter dietary supplement. Read More

UK shareholder meetings calendar - next 7 days

23rd Nov 2023 15:53

Read More

See more MXC.L news
FTSE 100 Latest
Value8,809.74
Change53.53

Login to your account

Forgot Password?

Not Registered